Satellite Chemical Co.,Ltd. (SHE:002648)
China · Delayed Price · Currency is CNY 27.86
-0.74 (-2.59%)
Apr 8, 2026, 3:04 PM CST
Satellite Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 38,736 | 42,049 | 40,237 | 36,766 | 28,214 |
Other Revenue | 7,332 | 3,600 | 1,250 | 276.78 | 343.13 |
| 46,068 | 45,648 | 41,487 | 37,043 | 28,557 | |
Revenue Growth (YoY) | 0.92% | 10.03% | 12.00% | 29.72% | 165.09% |
Cost of Revenue | 35,813 | 34,922 | 33,266 | 30,922 | 19,515 |
Gross Profit | 10,255 | 10,726 | 8,221 | 6,121 | 9,042 |
Selling, General & Admin | 650.53 | 885.01 | 676.09 | 628.75 | 569.6 |
Research & Development | 1,656 | 1,751 | 1,626 | 1,241 | 1,075 |
Other Operating Expenses | 12.48 | 3.12 | 0.15 | 120.01 | 95.15 |
Operating Expenses | 2,330 | 2,653 | 2,304 | 2,005 | 1,751 |
Operating Income | 7,926 | 8,073 | 5,917 | 4,116 | 7,290 |
Interest Expense | -963.51 | -1,082 | -1,208 | -429.66 | -557.07 |
Interest & Investment Income | 227.3 | 167.33 | 224.77 | 578.83 | 267.9 |
Currency Exchange Gain (Loss) | -125.16 | -86.45 | 197.02 | -130.66 | 18.32 |
Other Non Operating Income (Expenses) | -34.18 | -67.74 | -24.47 | -457.78 | -39.72 |
EBT Excluding Unusual Items | 7,030 | 7,004 | 5,105 | 3,677 | 6,980 |
Gain (Loss) on Sale of Investments | -1,006 | 157.12 | 173.59 | -290.56 | -31.05 |
Gain (Loss) on Sale of Assets | 10.29 | 0 | 0.47 | 2.93 | 0.38 |
Asset Writedown | -56.67 | -261.18 | -13.55 | -4.59 | -38.95 |
Other Unusual Items | 87.84 | 117.91 | 102.17 | 60.07 | 82.96 |
Pretax Income | 6,066 | 7,018 | 5,368 | 3,445 | 6,993 |
Income Tax Expense | 760.62 | 956.12 | 584.27 | 334.42 | 980.41 |
Earnings From Continuing Operations | 5,305 | 6,062 | 4,784 | 3,111 | 6,013 |
Net Income to Company | 5,305 | 6,062 | 4,784 | 3,111 | 6,013 |
Minority Interest in Earnings | 5.35 | 9.88 | 5.74 | -14.82 | -6.28 |
Net Income | 5,311 | 6,072 | 4,789 | 3,096 | 6,007 |
Net Income to Common | 5,311 | 6,072 | 4,789 | 3,096 | 6,007 |
Net Income Growth | -12.54% | 26.77% | 54.71% | -48.46% | 261.62% |
Shares Outstanding (Basic) | 3,361 | 3,373 | 3,373 | 3,365 | 3,356 |
Shares Outstanding (Diluted) | 3,361 | 3,373 | 3,373 | 3,365 | 3,374 |
Shares Change (YoY) | -0.35% | 0.01% | 0.24% | -0.28% | 12.00% |
EPS (Basic) | 1.58 | 1.80 | 1.42 | 0.92 | 1.79 |
EPS (Diluted) | 1.58 | 1.80 | 1.42 | 0.92 | 1.78 |
EPS Growth | -12.23% | 26.76% | 54.35% | -48.32% | 222.87% |
Free Cash Flow | 6,947 | 7,450 | 5,590 | 1,971 | -394.89 |
Free Cash Flow Per Share | 2.07 | 2.21 | 1.66 | 0.59 | -0.12 |
Dividend Per Share | 0.500 | 0.500 | 0.400 | 0.400 | 0.178 |
Dividend Growth | - | 25.00% | - | 124.34% | 187.58% |
Gross Margin | 22.26% | 23.50% | 19.82% | 16.52% | 31.66% |
Operating Margin | 17.21% | 17.69% | 14.26% | 11.11% | 25.53% |
Profit Margin | 11.53% | 13.30% | 11.54% | 8.36% | 21.03% |
Free Cash Flow Margin | 15.08% | 16.32% | 13.47% | 5.32% | -1.38% |
EBITDA | 12,692 | 12,559 | 8,199 | 5,615 | 8,353 |
EBITDA Margin | 27.55% | 27.51% | 19.76% | 15.16% | 29.25% |
D&A For EBITDA | 4,766 | 4,486 | 2,282 | 1,499 | 1,063 |
EBIT | 7,926 | 8,073 | 5,917 | 4,116 | 7,290 |
EBIT Margin | 17.21% | 17.69% | 14.26% | 11.11% | 25.53% |
Effective Tax Rate | 12.54% | 13.62% | 10.88% | 9.71% | 14.02% |
Revenue as Reported | 46,068 | 45,648 | 41,487 | 37,043 | 28,557 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.